Literature DB >> 12034754

Initial activation of cyclin-B1-cdc2 kinase requires phosphorylation of cyclin B1.

Marion Peter1, Christian Le Peuch, Jean-Claude Labbé, April N Meyer, Daniel J Donoghue, Marcel Dorée.   

Abstract

At the G(2)/M transition of the cell cycle, the cdc25c phosphatase dephosphorylates inhibitory residues of cdc2, and cyclin-B-cdc2 kinase (MPF) is activated. Phosphorylation of cyclin B1 induces its nuclear accumulation, and, since cdc25c is also believed to accumulate and activate shortly before G(2)/M in the nucleus, it has been proposed that this induces cyclin-B1-cdc2 kinase activation. We demonstrate that cyclin B1 phosphorylation has another essential function in vivo: it is required for cdc25c and MPF activation, which does not require nuclear accumulation of cyclin B1, and occurs in the cytoplasm.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12034754      PMCID: PMC1084145          DOI: 10.1093/embo-reports/kvf111

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  40 in total

1.  Translocation of cyclin B1 to the nucleus at prophase requires a phosphorylation-dependent nuclear import signal.

Authors:  A Hagting; M Jackman; K Simpson; J Pines
Journal:  Curr Biol       Date:  1999-07-01       Impact factor: 10.834

2.  Absence of Wee1 ensures the meiotic cell cycle in Xenopus oocytes.

Authors:  N Nakajo; S Yoshitome; J Iwashita; M Iida; K Uto; S Ueno; K Okamoto; N Sagata
Journal:  Genes Dev       Date:  2000-02-01       Impact factor: 11.361

3.  The APC is dispensable for first meiotic anaphase in Xenopus oocytes.

Authors:  M Peter; A Castro; T Lorca; C Le Peuch; L Magnaghi-Jaulin; M Dorée; J C Labbé
Journal:  Nat Cell Biol       Date:  2001-01       Impact factor: 28.824

Review 4.  Control of mitosis by changes in the subcellular location of cyclin-B1-Cdk1 and Cdc25C.

Authors:  C G Takizawa; D O Morgan
Journal:  Curr Opin Cell Biol       Date:  2000-12       Impact factor: 8.382

5.  Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase.

Authors:  F Toyoshima-Morimoto; E Taniguchi; N Shinya; A Iwamatsu; E Nishida
Journal:  Nature       Date:  2001-03-08       Impact factor: 49.962

6.  The polo-like kinase Plx1 is required for activation of the phosphatase Cdc25C and cyclin B-Cdc2 in Xenopus oocytes.

Authors:  Y W Qian; E Erikson; F E Taieb; J L Maller
Journal:  Mol Biol Cell       Date:  2001-06       Impact factor: 4.138

7.  Cytoplasmic control of nuclear behavior during meiotic maturation of frog oocytes.

Authors:  Y Masui; C L Markert
Journal:  J Exp Zool       Date:  1971-06

8.  Role of nuclear material in the early cell cycle of Xenopus embryos.

Authors:  M C Dabauvalle; M Doree; R Bravo; E Karsenti
Journal:  Cell       Date:  1988-02-26       Impact factor: 41.582

9.  New B-type cyclin synthesis is required between meiosis I and II during Xenopus oocyte maturation.

Authors:  H Hochegger; A Klotzbücher; J Kirk; M Howell; K le Guellec; K Fletcher; T Duncan; M Sohail; T Hunt
Journal:  Development       Date:  2001-10       Impact factor: 6.868

Review 10.  From Cdc2 to Cdk1: when did the cell cycle kinase join its cyclin partner?

Authors:  Marcel Dorée; Tim Hunt
Journal:  J Cell Sci       Date:  2002-06-15       Impact factor: 5.285

View more
  9 in total

1.  Localization and dynamics of Cdc2-cyclin B during meiotic reinitiation in starfish oocytes.

Authors:  Mark Terasaki; Ei-Ichi Okumura; Beth Hinkle; Takeo Kishimoto
Journal:  Mol Biol Cell       Date:  2003-08-07       Impact factor: 4.138

2.  Distinct pools of cdc25C are phosphorylated on specific TP sites and differentially localized in human mitotic cells.

Authors:  Celine Franckhauser; Daria Mamaeva; Lisa Heron-Milhavet; Anne Fernandez; Ned J C Lamb
Journal:  PLoS One       Date:  2010-07-26       Impact factor: 3.240

3.  Release from meiotic arrest in ascidian eggs requires the activity of two phosphatases but not CaMKII.

Authors:  Mark Levasseur; Remi Dumollard; Jean-Philippe Chambon; Celine Hebras; Maureen Sinclair; Michael Whitaker; Alex McDougall
Journal:  Development       Date:  2013-11       Impact factor: 6.868

4.  Prognostic significance of G2/M arrest signaling pathway proteins in advanced non-small cell lung cancer patients.

Authors:  Jing Wang; Yuhai Zhang; Shudi Xu; Weijie Li; Zhangqin Chen; Zhe Wang; Xinpeng Han; Yiling Zhao; Shengqing Li
Journal:  Oncol Lett       Date:  2015-01-02       Impact factor: 2.967

5.  A High-Resolution Proteomic Landscaping of Primary Human Dental Stem Cells: Identification of SHED- and PDLSC-Specific Biomarkers.

Authors:  Vasiliki Taraslia; Stefania Lymperi; Vasiliki Pantazopoulou; Athanasios K Anagnostopoulos; Issidora S Papassideri; Efthimia K Basdra; Marianna Bei; Evangelos G Kontakiotis; George Th Tsangaris; Dimitrios J Stravopodis; Ema Anastasiadou
Journal:  Int J Mol Sci       Date:  2018-01-05       Impact factor: 5.923

6.  Cyclin B2 can compensate for Cyclin B1 in oocyte meiosis I.

Authors:  Jian Li; Ji-Xin Tang; Jin-Mei Cheng; Bian Hu; Yu-Qian Wang; Batool Aalia; Xiao-Yu Li; Cheng Jin; Xiu-Xia Wang; Shou-Long Deng; Yan Zhang; Su-Ren Chen; Wei-Ping Qian; Qing-Yuan Sun; Xing-Xu Huang; Yi-Xun Liu
Journal:  J Cell Biol       Date:  2018-08-10       Impact factor: 10.539

7.  FGFR1 Overexpression Induces Cancer Cell Stemness and Enhanced Akt/Erk-ER Signaling to Promote Palbociclib Resistance in Luminal A Breast Cancer Cells.

Authors:  Qiong Cheng; Zhikun Ma; Yujie Shi; Amanda B Parris; Lingfei Kong; Xiaohe Yang
Journal:  Cells       Date:  2021-11-04       Impact factor: 6.600

8.  miR‑342‑5p promotes Zmpste24‑deficient mouse embryonic fibroblasts proliferation by suppressing GAS2.

Authors:  Chun-Long Zhang; Xinguang Liu; Qiu-Jing He; Huiling Zheng; Shun Xu; Xing-Dong Xiong; Yuan Yuan; Jie Ruan; Jiang-Bin Li; Yu Xing; Zhongjun Zhou; Shixiong Deng
Journal:  Mol Med Rep       Date:  2017-10-05       Impact factor: 2.952

9.  Programmed Cell Death Alterations Mediated by Synthetic Indole Chalcone Resulted in Cell Cycle Arrest, DNA Damage, Apoptosis and Signaling Pathway Modulations in Breast Cancer Model.

Authors:  Radka Michalkova; Martin Kello; Zuzana Kudlickova; Maria Gazdova; Ladislav Mirossay; Gabriela Mojzisova; Jan Mojzis
Journal:  Pharmaceutics       Date:  2022-02-24       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.